Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Equifax (EFX) Shares Outstanding (Diluted Average) (2016 - 2025)

Equifax's Shares Outstanding (Diluted Average) history spans 17 years, with the latest figure at $124.1 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) fell 0.64% year-over-year to $124.1 million; the TTM value through Dec 2025 reached $124.1 million, down 0.64%, while the annual FY2025 figure was $124.1 million, 0.64% down from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $124.1 million at Equifax, roughly flat from $124.7 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $125.1 million in Q1 2025 and bottomed at $123.2 million in Q1 2021.
  • The 5-year median for Shares Outstanding (Diluted Average) is $123.8 million (2023), against an average of $124.0 million.
  • The largest annual shift saw Shares Outstanding (Diluted Average) grew 1.05% in 2024 before it dropped 0.64% in 2025.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $123.6 million in 2021, then decreased by 0.24% to $123.3 million in 2022, then grew by 0.49% to $123.9 million in 2023, then rose by 0.81% to $124.9 million in 2024, then fell by 0.64% to $124.1 million in 2025.
  • Per Business Quant, the three most recent readings for EFX's Shares Outstanding (Diluted Average) are $124.1 million (Q4 2025), $124.7 million (Q3 2025), and $125.0 million (Q2 2025).